Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
Clinical trial NCT02876224 · COMPLETED
Trial details
- NCT number
- NCT02876224
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-30
- Primary completion
- 2019-06-25
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.